Annual CFI
-$29.07 M
+$19.08 M+39.62%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual cash flow from investing activities is currently -$29.07 million, with the most recent change of +$19.08 million (+39.62%) on 31 December 2023. During the last 3 years, it has fallen by -$20.51 million (-239.44%). TNXP annual CFI is now -275.66% below its all-time high of $16.55 million, reached on 31 December 2016.TNXP Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$9000.00
-$9000.00-100.00%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly cash flow from investing activities is currently -$9000.00, with the most recent change of -$9000.00 (-100.00%) on 30 September 2024. Over the past year, it has increased by +$812.00 thousand (+98.90%). TNXP quarterly CFI is now -100.17% below its all-time high of $5.24 million, reached on 30 September 2016.TNXP Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$548.00 K
+$812.00 K+59.71%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding TTM cash flow from investing activities is currently -$548.00 thousand, with the most recent change of +$812.00 thousand (+59.71%) on 30 September 2024. Over the past year, it has increased by +$32.76 million (+98.35%). TNXP TTM CFI is now -103.31% below its all-time high of $16.55 million, reached on 31 December 2016.TNXP TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.6% | +98.9% | +98.3% |
| 3 y3 years | -239.4% | +99.9% | +96.2% |
| 5 y5 years | -10000.0% | -350.0% | -4881.8% |
TNXP Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -239.4% | +39.6% | +100.0% | at high | +99.2% | |
| 5 y | 5 years | <-9999.0% | +39.6% | +100.0% | -5380.0% | +99.2% | |
| alltime | all time | -275.7% | +39.6% | -100.2% | +100.0% | -103.3% | +99.2% |
Tonix Pharmaceuticals Holding Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9000.00(<-9900.0%) | -$548.00 K(-59.7%) |
| June 2024 | - | $0.00(-100.0%) | -$1.36 M(-94.6%) |
| Mar 2024 | - | -$108.00 K(-74.9%) | -$25.38 M(-12.7%) |
| Dec 2023 | -$29.07 M(-39.6%) | -$431.00 K(-47.5%) | -$29.07 M(-12.7%) |
| Sept 2023 | - | -$821.00 K(-96.6%) | -$33.31 M(-19.4%) |
| June 2023 | - | -$24.02 M(+532.2%) | -$41.31 M(+30.2%) |
| Mar 2023 | - | -$3.80 M(-18.7%) | -$31.73 M(-34.1%) |
| Dec 2022 | -$48.15 M(+36.4%) | -$4.67 M(-47.0%) | -$48.15 M(-30.3%) |
| Sept 2022 | - | -$8.82 M(-38.9%) | -$69.10 M(+1.6%) |
| June 2022 | - | -$14.44 M(-28.6%) | -$68.03 M(+23.6%) |
| Mar 2022 | - | -$20.22 M(-21.1%) | -$55.02 M(+55.8%) |
| Dec 2021 | -$35.31 M(+312.3%) | -$25.62 M(+230.6%) | -$35.31 M(+148.3%) |
| Sept 2021 | - | -$7.75 M(+442.4%) | -$14.22 M(+35.6%) |
| June 2021 | - | -$1.43 M(+183.0%) | -$10.48 M(+15.6%) |
| Mar 2021 | - | -$505.00 K(-88.9%) | -$9.07 M(+5.9%) |
| Dec 2020 | -$8.56 M(>+9900.0%) | -$4.53 M(+12.9%) | -$8.56 M(+112.2%) |
| Sept 2020 | - | -$4.02 M(>+9900.0%) | -$4.04 M(>+9900.0%) |
| June 2020 | - | -$14.00 K(<-9900.0%) | -$21.00 K(+110.0%) |
| Mar 2020 | - | $0.00(-100.0%) | -$10.00 K(-41.2%) |
| Dec 2019 | -$17.00 K(+183.3%) | -$5000.00(+150.0%) | -$17.00 K(+54.5%) |
| Sept 2019 | - | -$2000.00(-33.3%) | -$11.00 K(-8.3%) |
| June 2019 | - | -$3000.00(-57.1%) | -$12.00 K(+9.1%) |
| Mar 2019 | - | -$7000.00(-800.0%) | -$11.00 K(+83.3%) |
| Dec 2018 | -$6000.00(-100.1%) | $1000.00(-133.3%) | -$6000.00(-40.0%) |
| Sept 2018 | - | -$3000.00(+50.0%) | -$10.00 K(+42.9%) |
| June 2018 | - | -$2000.00(0.0%) | -$7000.00(-100.3%) |
| Mar 2018 | - | -$2000.00(-33.3%) | $2.47 M(-65.5%) |
| Dec 2017 | $7.17 M | -$3000.00(<-9900.0%) | $7.17 M(-35.0%) |
| Sept 2017 | - | $0.00(-100.0%) | $11.03 M(-32.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $2.48 M(-47.2%) | $16.27 M(-1.5%) |
| Mar 2017 | - | $4.69 M(+21.7%) | $16.52 M(-0.1%) |
| Dec 2016 | $16.55 M(-168.5%) | $3.86 M(-26.4%) | $16.55 M(+53.7%) |
| Sept 2016 | - | $5.24 M(+91.7%) | $10.77 M(-165.0%) |
| June 2016 | - | $2.73 M(-42.1%) | -$16.57 M(-14.8%) |
| Mar 2016 | - | $4.72 M(-345.1%) | -$19.45 M(-19.5%) |
| Dec 2015 | -$24.17 M(+6066.1%) | -$1.93 M(-91.3%) | -$24.17 M(+8.0%) |
| Sept 2015 | - | -$22.09 M(>+9900.0%) | -$22.37 M(+5007.5%) |
| June 2015 | - | -$153.00 K(<-9900.0%) | -$438.00 K(+12.3%) |
| Mar 2015 | - | $0.00(-100.0%) | -$390.00 K(-0.5%) |
| Dec 2014 | -$392.00 K(+2513.3%) | -$125.00 K(-21.9%) | -$392.00 K(+43.1%) |
| Sept 2014 | - | -$160.00 K(+52.4%) | -$274.00 K(+124.6%) |
| June 2014 | - | -$105.00 K(+5150.0%) | -$122.00 K(+617.6%) |
| Mar 2014 | - | -$2000.00(-71.4%) | -$17.00 K(+13.3%) |
| Dec 2013 | -$15.00 K(-58.3%) | -$7000.00(-12.5%) | -$15.00 K(+80.7%) |
| Sept 2013 | - | -$8000.00(<-9900.0%) | -$8300.00(+277.3%) |
| June 2013 | - | $0.00(0.0%) | -$2200.00(-93.9%) |
| Mar 2013 | - | $0.00(-100.0%) | -$36.00 K(0.0%) |
| Dec 2012 | -$36.00 K(<-9900.0%) | -$300.00(-84.2%) | -$36.00 K(+0.8%) |
| Sept 2012 | - | -$1900.00(-94.4%) | -$35.70 K(+5.6%) |
| June 2012 | - | -$33.80 K(<-9900.0%) | -$33.80 K(+131.5%) |
| Mar 2012 | - | $0.00(0.0%) | -$14.60 K(-3750.0%) |
| Dec 2011 | $300.00(-100.3%) | $0.00(0.0%) | $400.00(-100.4%) |
| Sept 2011 | - | $0.00(-100.0%) | -$94.00 K(0.0%) |
| June 2011 | - | -$14.60 K(-197.3%) | -$94.00 K(+18.4%) |
| Mar 2011 | - | $15.00 K(-115.9%) | -$79.40 K(-15.9%) |
| Dec 2010 | -$94.40 K | -$94.40 K(<-9900.0%) | -$94.40 K(<-9900.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00 | $0.00 |
FAQ
- What is Tonix Pharmaceuticals Holding annual cash flow from investing activities?
- What is the all time high annual CFI for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual CFI year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly CFI year-on-year change?
- What is Tonix Pharmaceuticals Holding TTM cash flow from investing activities?
- What is the all time high TTM CFI for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding TTM CFI year-on-year change?
What is Tonix Pharmaceuticals Holding annual cash flow from investing activities?
The current annual CFI of TNXP is -$29.07 M
What is the all time high annual CFI for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual cash flow from investing activities is $16.55 M
What is Tonix Pharmaceuticals Holding annual CFI year-on-year change?
Over the past year, TNXP annual cash flow from investing activities has changed by +$19.08 M (+39.62%)
What is Tonix Pharmaceuticals Holding quarterly cash flow from investing activities?
The current quarterly CFI of TNXP is -$9000.00
What is the all time high quarterly CFI for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly cash flow from investing activities is $5.24 M
What is Tonix Pharmaceuticals Holding quarterly CFI year-on-year change?
Over the past year, TNXP quarterly cash flow from investing activities has changed by +$812.00 K (+98.90%)
What is Tonix Pharmaceuticals Holding TTM cash flow from investing activities?
The current TTM CFI of TNXP is -$548.00 K
What is the all time high TTM CFI for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high TTM cash flow from investing activities is $16.55 M
What is Tonix Pharmaceuticals Holding TTM CFI year-on-year change?
Over the past year, TNXP TTM cash flow from investing activities has changed by +$32.76 M (+98.35%)